These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26369814)

  • 1. Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future.
    Burke MP; Borland KM; Litosh VA
    Curr Top Med Chem; 2016; 16(11):1231-41. PubMed ID: 26369814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
    Damaraju D; Damaraju VL; Brun M; Mowles D; Kuzma M; Berendt RC; Sawyer MB; Cass CE
    Biochem Pharmacol; 2008 May; 75(10):1901-11. PubMed ID: 18371936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New nucleoside analogs in the treatment of solid tumors.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(4):297-305. PubMed ID: 15575597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites.
    Elgemeie GH
    Curr Pharm Des; 2003; 9(31):2627-42. PubMed ID: 14529546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine nucleoside antimetabolites in development for the treatment of cancer.
    Parker WB; Secrist JA; Waud WR
    Curr Opin Investig Drugs; 2004 Jun; 5(6):592-6. PubMed ID: 15242246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older and new purine nucleoside analogs for patients with acute leukemias.
    Robak P; Robak T
    Cancer Treat Rev; 2013 Dec; 39(8):851-61. PubMed ID: 23566572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro growth inhibitory activity of novel silyl- and trityl-modified nucleosides.
    Panayides JL; Mathieu V; Banuls LM; Apostolellis H; Dahan-Farkas N; Davids H; Harmse L; Rey ME; Green IR; Pelly SC; Kiss R; Kornienko A; van Otterlo WA
    Bioorg Med Chem; 2016 Jun; 24(12):2716-24. PubMed ID: 27157005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
    Van den Neste E; Cardoen S; Offner F; Bontemps F
    Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancement in the development of heterocyclic nucleosides for the treatment of cancer - A review.
    Mirza AZ
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(11):836-857. PubMed ID: 31135268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triazole nucleoside derivatives bearing aryl functionalities on the nucleobases show antiviral and anticancer activity.
    Xia Y; Qu F; Peng L
    Mini Rev Med Chem; 2010 Aug; 10(9):806-21. PubMed ID: 20482498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.
    Hassan AEA; Abou-Elkhair RAI; Parker WB; Allan PW; Secrist JA
    Eur J Med Chem; 2016 Jan; 108():616-622. PubMed ID: 26724729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside transporters: biological insights and therapeutic applications.
    Choi JS; Berdis AJ
    Future Med Chem; 2012 Jul; 4(11):1461-78. PubMed ID: 22857534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress for the synthesis of selected carbocyclic nucleosides.
    Bessières M; Chevrier F; Roy V; Agrofoglio LA
    Future Med Chem; 2015; 7(13):1809-28. PubMed ID: 26416300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
    Robak T; Lech-Maranda E; Korycka A; Robak E
    Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it still worth renewing nucleoside anticancer drugs nowadays?
    Liu ZQ
    Eur J Med Chem; 2024 Jan; 264():115987. PubMed ID: 38056297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keto and exomethylene pyranonucleosides as antitumor agents.
    Tsoukala E; Manta S; Kiritsis C; Komiotis D
    Mini Rev Med Chem; 2012 Mar; 12(3):255-75. PubMed ID: 22303938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Nucleosides as chemotherapeutic agents.
    Gumina G; Song GY; Chu CK
    FEMS Microbiol Lett; 2001 Aug; 202(1):9-15. PubMed ID: 11506901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
    Galmarini CM; Popowycz F; Joseph B
    Curr Med Chem; 2008; 15(11):1072-82. PubMed ID: 18473803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New nucleoside analogs in the treatment of hematological disorders.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(3):223-32. PubMed ID: 15481249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues.
    Sivakrishna B; Islam S; Panda A; Saranya M; Santra MK; Pal S
    Anticancer Agents Med Chem; 2018; 18(10):1425-1431. PubMed ID: 29577866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.